Research Topics
| Bruno VellasSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trialBruno Vellas
INSERM U1027, Toulouse, France
Lancet Neurol 11:851-9. 2012..We aimed to assess efficacy of long-term use of standardised ginkgo biloba extract for the reduction of incidence of Alzheimer's disease in elderly adults with memory complaints...
Editorial: recruitment, retention and other methodological issues related to clinical trials for Alzheimer's diseaseB Vellas
B Vellas, Gerontopole, Inserm U 1027, Alzheimer s Disease Research and Clinical Center, Toulouse, University Hospital, France
J Nutr Health Aging 16:330. 2012..The MAPT Study...
[Consensus statement on severe dementia]B Vellas
CHU Casselardit, secteur A gériatrie, Toulouse
Presse Med 34:1545-55. 2005..The group also stressed the importance of clinical research to improve knowledge of disease course and assess management strategies and recommended specific area for research...
Memory health clinics-a first step to preventionBruno Vellas
Department of Internal Medicine and Clinical Gerontology, Gerontopole, Toulouse Université Hospital, CHU La Grave Casselardit, Toulouse, France Inserm U 558, Toulouse, France
Alzheimers Dement 4:S144-9. 2008..Leon Thal suggested that this could have a much bigger impact than all the drugs we might ever hope to develop. The main objective of this article is to present the rationale for multi-domain preventive approaches...
Editorial: use of biomarkers in Alzheimer's trialsB Vellas
B Vellas, , U 558, Alzheimer s Disease Clinical Research Center, CHU Toulouse, France, E mail
J Nutr Health Aging 13:331. 2009..The aims of the Gispen study were to evaluate the validity of biomarkers that are currently being proposed as potential surrogate endpoints. We really think that this journal's special issue can contribute in this field...
Commentary: a brief history of geriatricsBruno Vellas
Centre de Geriatrie Toulouse, 170 Ave. de Casselardit, 31300 Toulouse, France
J Gerontol A Biol Sci Med Sci 59:1171-2; discussion 1132-52. 2004
The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaintB Vellas
INSERM French National Institute of Health and Medical Research, U558, F 31073 Toulouse, France
Neurology 67:S6-11. 2006..In the past, several studies suggest that Ginkgo biloba could have a potential benefit effect on cognitive function. The aim of the GuidAge Study is to evaluate the efficacy of 240 mg/d of EGb 761 in the prevention of AD...
Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatmentB Vellas
Department of Internal Medicine and Clinical Gerongology, Centre Hospitalier Universitaire Purpan Casselardit, F 31300 Toulouse, France
J Nutr Health Aging 9:75-80. 2005..However, information on the evolution of nutritional status and its impact on the prognosis of AD is still scarce...
Disease modifying trials in Alzheimer's disease: perspectives for the futureBruno Vellas
Gerontopole, CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
J Alzheimers Dis 15:289-301. 2008....
[Alzheimer's disease: 160,000 new cases each year in France]Bruno Vellas
, CHU Casselardit, 31300 Toulouse
Rev Prat 55:1867-8. 2005
[Consensus statement on severe dementia]B Vellas
CHU Casselardit, Toulouse
Rev Neurol (Paris) 161:868-77. 2005..Resource allocation and proximity care have to be targeted. Research areas necessary to improve the care of patients with severe dementia has been selected...
Overview of the MNA--Its history and challengesB Vellas
INSERM U 558, Department of Geriatrics, Toulouse University Hospital, Toulouse, France
J Nutr Health Aging 10:456-63; discussion 463-5. 2006..A short screening version (MNA-SF) has been developed, which, if positive, indicates the need to complete the full MNA. It takes less than 4 minutes to administer the MNA-SF and between 10 and 15 minutes for the full MNA...
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody respondersBruno Vellas
Department of Geriatrics INSERM U 558, Toulouse University Hospital Center, Toulouse, France
Curr Alzheimer Res 6:144-51. 2009..One year follow-up revealed that AN1792 antibody responders showed improvements in cognitive measures as assessed by the neuropsychological test battery (NTB) and a decrease in brain volume compared with placebo...
Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR studySandrine Sourdet
Internal Medicine Service and Gerontology Clinic, Hopital La Grave Casselardit, Toulouse, France
J Am Med Dir Assoc 13:407.e1-6. 2012..The aim of this study was to explore the predictive value of an abnormal one-leg balance (OLB) test for functional decline, nursing home admission, and mortality in community-dwelling patients affected with Alzheimer's disease (AD)...
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitorsSophie Gillette-Guyonnet
Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire La Grave Casselardit, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
J Gerontol A Biol Sci Med Sci 61:516-20. 2006..This study aims to investigate the effect of CEIs on three clinically relevant domains (rapid cognitive decline, institutionalization, and weight loss) in patients with Alzheimer's disease...
Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-upOlivier Guerin
INSERM U558, Department of Internal Medicine and Clinical Gerontology, CHU de Toulouse, Universite Paul Sabatier, France
Clin Nutr 28:141-6. 2009..Weight loss in Alzheimer's disease (AD) may be either progressive or rapid, with different consequences. The aim of this study was to characterize massive weight loss (>or= 5 kg over 6 months) during a 6.5-year follow-up...
Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's diseaseMaria E Soto
Alzheimer s Disease Research and Clinical Centre, Department of Geriatric Medicine, Gerontopole, Toulouse University Hospital, Toulouse, France
J Alzheimers Dis 28:647-54. 2012..50, 95% CI = 1.04-2.17). In conclusion, weight loss predicted RCD in this cohort. Whether the prevention of weight loss (by improving nutritional status) impacts cognitive decline remains an open question...
Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's diseaseMaria E Soto
Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
Dement Geriatr Cogn Disord 26:109-16. 2008..Given the poorer prognosis of Alzheimer's disease (AD) patients with rapid cognitive decline (RCD), there is a need for a clinical assessment tool to detect these patients...
Long-term progression of Alzheimer's disease in patients under antidementia drugsSophie Gillette-Guyonnet
Department of Internal Medicine and Geriatrics, Purpan University Hospital, Gerontopole Toulouse University Hospital, France
Alzheimers Dement 7:579-92. 2011..Data regarding the long-term disease progression outside of therapeutic trials are lacking. We examined the effects of standard of care for AD patients on the prognosis of the disease in a real-life study over a 4-year period...
Special acute care unit for older adults with Alzheimer's diseaseMaria E Soto
CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
Int J Geriatr Psychiatry 23:215-9. 2008..To describe the cognitive, functional, and nutritional features of patients admitted to a Special Acute Care Unit (SACU) for elderly patients with Alzheimer's disease (AD)...
Wandering behavior and Alzheimer disease. The REAL.FR prospective studyYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Pavillon Junot, Hopital La Grave Casselardit, 170 avenue de Casselardit, Toulouse, France
Alzheimer Dis Assoc Disord 21:31-8. 2007..Risk for undernutrition and death are not increased in wanderers. Their higher risk of ADL disabilities and institutionalization are partly explained by their baseline characteristics...
A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort)Fati Nourhashemi
CHU Toulouse, Hôpital Casselardit, Service de médecine interne et gérontologie clinique, Toulouse, France
Int J Geriatr Psychiatry 23:460-5. 2008..The primary objective of our study was to examine the evolution of AD in individuals with very mild AD (CDR 0.5) across a 2-year follow up...
Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR StudyFrederic Cortes
Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan Casselardit, Toulouse, France
Alzheimers Dement 4:22-9. 2008..The aim of the present study was to describe the long-term evolution of Alzheimer's disease (AD) in a prospective cohort of patients under treatment with a close follow-up...
GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline dataSandrine Andrieu
INSERM, U558, F 31073, Toulouse, France
Curr Alzheimer Res 5:406-15. 2008..5% presented a CDR score of 0.5. This study will enable us to evaluate the efficacy of EGb761 in the prevention of AD, and to assess the usefulness of various baseline characteristics as predictors of conversion to AD in this population...
An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's diseaseYves Rolland
INSERM, U558, Toulouse, France
J Alzheimers Dis 16:525-31. 2009..8 (0.3) points at two years (p < 0.001). An abnormal one-leg balance test is a marker of more advanced dementia and predicts a higher rate of cognitive decline...
Treatment strategies for sarcopenia and frailtyYves Rolland
INSERM U1027, F 31073, Avenue Jules Guesdes, University of Toulouse III, F 31073, France
Med Clin North Am 95:427-38, ix. 2011..The quality of amino acids in the diet is an important factor for stimulating protein synthesis. Vitamin D deficiency should be treated, and new pharmacologic approaches for sarcopenia are currently assessed...
Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional studyYves Rolland
Internal Medicine Service and Gerontology Clinic, Hopital La Grave Casselardit, Toulouse, France
J Am Geriatr Soc 51:1120-4. 2003..To determine whether calf circumference (CC), related to appendicular skeletal muscle mass, can be used as a measure of sarcopenia and is related to physical function...
Risk factors for functional decline and institutionalisation among community-dwelling older adults with mild to severe Alzheimer's disease: one year of follow-upMaria E Soto
, CHU Purpan-Casselardit, Toulouse, , France
Age Ageing 35:308-10. 2006
Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) StudyYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, Toulouse, France
Am J Clin Nutr 89:1895-900. 2009..In elders, decreased muscle mass (sarcopenia) and increased fat mass (obesity) may contribute to difficulties with physical function...
Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-upS Andrieu
Department of Internal Medicine and Clinical Gerontology, Alzheimer Center, 170 chemin de Casselardit, 31300 Toulouse, France
J Nutr Health Aging 5:113-7. 2001..006) were risk factors for institutional placement. Nutritional problems are reversible and patients with a low MNA score could benefit from a thorough geriatric assessment, in order to slow or prevent institutional placement...
Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)Fati Nourhashemi
Gerontopole, CMRR, Toulouse, France
BMJ 340:c2466. 2010..To test the effectiveness of a comprehensive specific care plan in decreasing the rate of functional decline in patients with mild to moderate Alzheimer's disease compared with usual care in memory clinics...
Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unitMaria E Soto
Department of Geriatric Medicine, Gérontopôle de Toulouse, Toulouse University Hospital, Toulouse, France
J Am Med Dir Assoc 13:486.e1-6. 2012..To describe hospitalizations in a Special Acute Care inpatient Unit for older adults with Alzheimer's disease (AD) and other related disorders...
Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohortGabor Abellan van Kan
Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
J Gerontol A Biol Sci Med Sci 67:425-32. 2012..The aim of the study was to evaluate whether GS, TLM, and TFM were associated factors with an increased risk for subsequent dementia in community-dwelling older women...
Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized studySylvie Lauque
Alzheimer Research and Clinical Center, Toulouse University Hospital, Toulouse, France
J Am Geriatr Soc 52:1702-7. 2004..To study the effects of oral nutritional supplements (OS) on body weight, body composition, nutritional status, and cognition in elderly patients with Alzheimer's disease (AD)...
Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS studySandrine Andrieu
Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
J Gerontol A Biol Sci Med Sci 58:372-7. 2003..The potential association between use of C4A treatments, in particular EGb 761 (standardized Ginkgo biloba extracts), and dementia of the Alzheimer type was investigated...
Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort studyVirginie Gardette
Department of Epidemiology and Public Health, Toulouse University Hospital, Université de Toulouse UPS, INSERM U558, Gerontopole, Toulouse, France
CNS Drugs 24:431-42. 2010..There is a lack of data concerning the optimal drug treatment duration and the reasons for discontinuation, particularly outside the clinical trial setting...
Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?B Vellas
B Vellas, INSERM U 558, Gerontopole, Pole Geriatrie, Centre Hospitalier Universitaire, Toulouse, France
J Nutr Health Aging 11:338-41. 2007..An impairment of more than 7 points at the ADAS-cog was found in 21% of the subjects at 18 months and was associated with loss...
Clinical trials on sarcopenia: methodological issues regarding phase 3 trialsGabor Abellan van Kan
Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, France
Clin Geriatr Med 27:471-82. 2011..The challenges to conduct phase 3 trials in the elderly should not offset the opportunities for the development of new strategies to counteract sarcopenia and prevent late-life disability...
Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 womenFati Nourhashemi
Department of Internal Medicine and Gerontology Clinic, CHU Purpan Casselardit, Toulouse, France
J Am Geriatr Soc 50:1796-801. 2002..To test the hypothesis that low fat-free soft tissue mass and cognitive impairment are independently associated...
Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohortChristophe Arbus
Paul Sabatier University, Department of Psychiatry and Medical Psychology, Purpan Casselardit Hospital, Toulouse, France
Int Psychogeriatr 22:120-8. 2010..The aim of this survey was to assess the prevalence of antidepressant use in AD and to identify the clinical factors associated with antidepressant prescription...
Gait and balance impairments in Alzheimer disease patientsVirginia Mazoteras Muñoz
Department of Geriatric Medicine, Univ Toulouse III, Toulouse, France
Alzheimer Dis Assoc Disord 24:79-84. 2010..To describe the characteristics and associated factors of Alzheimer disease (AD) patients with balance and gait impairments...
Body composition in French women 75+ years of age: the EPIDOS studySophie Gillette-Guyonnet
Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan Casselardit, 170 avenue de Casselardit, F 31300 Toulouse, France
Mech Ageing Dev 124:311-6. 2003..There are presently no published data on age-related changes in body composition in French individuals older than 65 or 80 years. This paper presents a cross-sectional study of 7518 community-residing French women older than 75 years...
Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR studyNicola Coley
INSERM, U558, University of Toulouse III, Toulouse, France
Neuroepidemiology 31:69-79. 2008..Attrition, i.e. patient dropout, can threaten the validity of results in longitudinal studies. The aim of this study was to identify patient and caregiver factors predictive of attrition in a cohort of Alzheimer disease (AD) patients...
Cardiovascular disease risk factors and progression of Alzheimer's diseaseGabor Abellan van Kan
INSERM U558, Department of Geriatric Medicine, CHU Toulouse, Toulouse, France
Dement Geriatr Cogn Disord 27:240-6. 2009..To assess if cardiovascular disease risk factors (CVDRF) are predictive factors for poorer evolution of Alzheimer's disease (AD) patients in terms of cognitive decline...
Comparison of bone mineral density and body composition measurements in women obtained from two DXA instrumentsSophie Gillette-Guyonnet
Department of Internal Medicine and Clinical Gerontology Pr JL Albarède, Centre Hospitalier Universitaire Purpan Casselardit, 170 avenue de Casselardit, F 31300 Toulouse, France
Mech Ageing Dev 124:317-21. 2003..However, due to the bone mineral inter-machine differences, comparisons of DXA measurements from different machines should be interpreted with caution...
Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional studyYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, Toulouse, France
Am J Clin Nutr 79:552-7. 2004..Muscle strength (MS) may be impaired in obese persons, and this impairment may be a consequence of both obesity and low physical fitness...
Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohortGabor Abellan van Kan
Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, 170, avenue de Casselardit, Toulouse 31059, France
Age Ageing 42:196-202. 2013..common pathophysiological pathways are shared between age-related body composition changes and cognitive impairment...
Prevention trials in Alzheimer's disease: an EU-US task force reportBruno Vellas
INSERM, U1027, F 31073, Toulouse, France
Prog Neurobiol 95:594-600. 2011....
Psychotropic drug consumption at admission and discharge of nursing home residentsYves Rolland
INSERM, Toulouse, France
J Am Med Dir Assoc 13:407.e7-12. 2012..To quantify transitions of residents into or out of nursing homes (NHs) and to describe psychotropic drug prescription at admission and discharge and with regard to dementia diagnosis...
Patterns of dementia treatment use in assisted living facilities: a cross-sectional study of 1975 demented residentsNadège Barro-Belaygues
Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
J Am Med Dir Assoc 12:648-54. 2011..To report the associated factors with the nonuse of cholinesterase-inhibitors and memantine in residents from assisted living (AL) facilities suffering from dementia...
Endpoints for trials in Alzheimer's disease: a European task force consensusBruno Vellas
INSERM U558, Toulouse, France
Lancet Neurol 7:436-50. 2008..A clear and consensual definition of endpoints is crucial for the success of further clinical trials in the field and will allow comparison of data across studies...
Nutritional status is associated with disease progression in very mild Alzheimer diseasePierre Jean Ousset
Department of Internal Medicine and Gerontology, Alzheimer Disease Center, CHU Purpan Casselardit, Toulouse, France
Alzheimer Dis Assoc Disord 22:66-71. 2008..Nutritional assessment should therefore form part of clinical evaluation of patients with AD at an early stage of the disease...
Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trialYves Rolland
Internal Medicine Service and Gerontology Clinic, Hopital La Grave Casselardit, Toulouse, France
J Am Geriatr Soc 55:158-65. 2007....
Physical performance measures as predictors of mortality in a cohort of community-dwelling older French womenYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, 31300, Toulouse, France
Eur J Epidemiol 21:113-22. 2006..Increased risk of death was partly explained by baseline health status and was absent in the healthiest elderly...
A SPECT study of wandering behavior in Alzheimer's diseaseYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, 170 avenue de Casselardit, 31300 Toulouse, France
Int J Geriatr Psychiatry 20:816-20. 2005..The aim of this study was to examine whether wandering during AD was associated with cerebral perfusion patterns measured by (99 m)Tc-labeled bicisate (ECD) brain SPECT...
Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR StudyFrederic Cortes
Service de médecine interne et gérontologie clinique, Toulouse, France
Am J Alzheimers Dis Other Demen 21:131-6. 2006....
The assessment of frailty in older adultsGabor Abellan van Kan
Gérontopôle de Toulouse, Department of Geriatric Medicine, Pavillon JP Junod, University Hospital Toulouse, CHU Toulouse, 170 avenue de Casselardit, TSA 40031, 31059 Toulouse Cedex 9, France
Clin Geriatr Med 26:275-86. 2010..The evaluation of gait speed over a short distance emerges from the literature as a tool with the capacity to identify frail older adults, and slow gait speed has been proven to be a strong predictor for frailty-adverse outcomes...
Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trialsNicola Coley
University of Toulouse III, France
Alzheimers Dement 7:602-610.e2. 2011..We evaluated the psychometric properties of the Clinical Dementia Rating-Sum of Boxes (CDR-SB) to assess its suitability as a single primary endpoint as an alternative to the traditional co-primary approach...
Disease-modifying trials in Alzheimer's disease: a European task force consensusBruno Vellas
Alzheimer Disease Research and Clinical Center, University of Toulouse, Toulouse, France
Lancet Neurol 6:56-62. 2007....
Associated factors with antipsychotic use in assisted living facilities: a cross-sectional study of 4367 residentsAgnes Larrayadieu
Department of Geriatric Medicine, Toulouse University Hospital Gérontopôle, 170, avenue de Casselardit, Toulouse 31059, France
Age Ageing 40:368-75. 2011..Even more, the prescription of these drugs is gradually increasing since the availability of second-generation atypical antipsychotics. More knowledge is needed on prescription reasons to understand this increasing prevalence...
Healthy brain aging: role of exercise and physical activityYves Rolland
INSERM U558, Avenue J Guesdes, F 31073 Toulouse, France
Clin Geriatr Med 26:75-87. 2010..Future prevention of Alzheimer disease may depend on lifestyle habits such as physical activity...
Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapyJulien Delrieu
Alzheimers Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
CNS Drugs 25:213-26. 2011..There is currently insufficient evidence for recommending combination therapy in Alzheimer's disease...
Mild Alzheimer's disease: a "position paper"J Delrieu
Service de medecine interne geriatrique et gerontologie clinique, Gerontopole, CHU Toulouse, Hopital Purpan Casselardit, Toulouse, France
J Nutr Health Aging 13:503-19. 2009..The critical analysis of international literature, conducted by Professor Bruno Vellas for the scientific committee, has served to support study of the latest knowledge in 2008...
A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's diseaseS Riviere
Department of Internal Medicine and Clinical Gerontology, Hopital La Grave Casselardit, Toulouse, France
J Nutr Health Aging 5:295-9. 2001..Weight loss is a common problem in patients with Alzheimer's Disease (AD). It is a predictive factor of mortality and it decreases patients' and caregivers' quality of life...
Current and future pharmacologic treatment of sarcopeniaYves Rolland
INSERM U1027, University of Toulouse III, Avenue Jules Guesdes, France
Clin Geriatr Med 27:423-47. 2011..Therefore, new pharmacologic agents may substantially reduce the functional decline in older people. This article reviews the new pharmacologic agents currently being assessed for treating sarcopenia...
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trialsBruno Vellas
Department of Geriatrics, INSERM U558, Toulouse University Hospital Center, Toulouse, France
Alzheimers Dement 7:e109-17. 2011..This article highlights some of the challenges faced by investigators when conducting clinical trials in AD, and it also offers some recommendations aimed at overcoming these challenges...
Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow studyJulien Delrieu
Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, Toulouse, France
Mov Disord 25:1288-91. 2010..We observed significant decrease of regional cerebral blood flow over the nondominant thalamus in sAHS+ compared to sAHS- patients. This result suggests the involvement of the nondominant thalamus in sAHS...
Cognitive impairment and composition of drinking water in women: findings of the EPIDOS StudySophie Gillette-Guyonnet
Service de médecine interne et gérontologie clinique, Hôpital Casselardit, Toulouse, France
Am J Clin Nutr 81:897-902. 2005..The concentration of aluminum or silica in drinking water may be a potential environmental risk factor for Alzheimer disease (AD)...
Dementia prevention: methodological explanations for inconsistent resultsNicola Coley
INSERM unit 558, Toulouse, France
Epidemiol Rev 30:35-66. 2008..Because of the multifactorial origin of dementia, it appears that multidomain interventions could be a suitable candidate for preventive interventions, but designing such trials remains very challenging for researchers...
Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's diseaseStéphanie Rivière
Department of Internal Medicine and Clinical Gerontology, Hopital La Grave Casselardit, Toulouse, France
Int J Geriatr Psychiatry 17:950-5. 2002..These behaviours lead to weight loss and frequently to physicians using tube feeding. Little is known about factors correlated with feeding difficulties during AD...
Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study)F Nourhashemi
Service de Médecine Interne et de, Toulouse, France
J Gerontol A Biol Sci Med Sci 56:M448-53. 2001..We investigated the associations between IADL incapacities and the various known correlates of frailty in a cohort of community-dwelling elderly women...
Nutritional intake and recreational physical activity in healthy elderly women living in the communityY Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hôpital Casselardit, Pavillon Junod, 31300 Toulouse, France
J Nutr Health Aging 9:397-402. 2005..Recreational physical activity, which increases energy expenditure, may help to maintain proper food intake. To compare the nutritional intake of inactive, active and very active healthy elderly women...
'Clinical trials in Alzheimer's disease': immunotherapy approachesJulien Delrieu
Alzheimer s Disease Clinical Research Centre, Gerontopole, Toulouse University Hospital, France INSERM 1027, France
J Neurochem 120:186-93. 2012..Currently, several Aβ peptide immunotherapy approaches are under investigation but also against tau pathology...
What are the treatment options for patients with severe Alzheimer's disease?Thierry Voisin
Alzheimer s Disease Research Centre, Toulouse University Hospital, 170 avenue de Casselardit, 31300 Toulouse, France
CNS Drugs 18:575-83. 2004..Increased attentiveness by clinicians to treatment response across this multidisciplinary spectrum in more advanced Alzheimer's disease is warranted...
[The Alzheimer's disease: how to estimate the impact of the pathology and the treatment?]Julien Delrieu
Centre de Recherche Clinique sur la Maladie d Alzheimer, Gerontopole, Hôpital Universitaire de Toulouse, Toulouse, France INSERM U558, Toulouse, France
Therapie 65:423-8. 2010..However, at present no biomarker is validated as surrogate endpoint. It seems today indispensable to use them in the therapeutic tries so as to validate and standardize their methods of acquisition, measure and analysis...
No additional benefit of HRT on response to rivastigmine in menopausal women with ADA S Rigaud
Department of Geriatrics, Broca Hospital, Paris, France
Neurology 60:148-9. 2003
Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?F Cortes
F Cortes, Alzheimer s Disease Research Centre, U 558, Toulouse, France
J Nutr Health Aging 11:330-7. 2007..Clinical trials in Alzheimer's disease (AD) include patients benefiting from recent improvements in AD management...
Determination of appendicular muscle mass by dual energy X-ray absorptiometry method in women with sarcopenia and Alzheimer's diseaseS Gillette-Guyonnet
Department of Gerontology and Internal Medicine, Purpan University Hospital, Toulouse, France
J Nutr Health Aging 4:165-9. 2000..To study appendicular muscle mass in women with Alzheimer's disease (AD) to investigate the association between sarcopenia and AD. To examine the AD associated changes in body fat distribution...
Balneotherapy, prevention of cognitive decline and care the Alzheimer patient and his family: outcome of a multidisciplinary workgroupM Secher
Service de medecine interne geriatrique et gerontologie clinique, Gerontopole, CHU Toulouse, Hopital Purpan Casselardit, Toulouse, France
J Nutr Health Aging 13:797-806. 2009..Considering ageing of the population, the number of Alzheimer's disease cases should raise to 1.3 million in 2020 (20 patients for 1000 inhabitants) ant 2.1 million in 2040 (30 patients for 1000 inhabitants)...
Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force)S Gillette Guyonnet
Gerontopole, Pole Geriatrie Gerontologie, Hopital La Grave Casselardit, Toulouse
J Nutr Health Aging 12:520-9. 2008....
Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective studySandrine Andrieu
Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
Int J Geriatr Psychiatry 17:422-6. 2002..To evaluate the frequency of and determine predictive factors for acute hospitalization in a prospective study of patients with Alzheimer's disease (AD)...
Early onset effects of galantamine treatment on attention in patients with Alzheimer's diseaseBruno Vellas
Memory Research Resource Center for Alzheimer's Disease, , , Toulouse, France
Curr Med Res Opin 21:1423-9. 2005..These effects may be a consequence of galantamine's potentiating action at nicotinic receptors...
Rehabilitation outcome of elderly patients with hip fracture and cognitive impairmentYves Rolland
Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, Toulouse, France
Disabil Rehabil 26:425-31. 2004..To assess the association between cognitive status and functional gain during a rehabilitation programme for elderly patients with hip fracture...
Alzheimer's disease progression in the oldest old compared to younger elderly patient: data from the REAL.FR studyFati Nourhashemi
Gérontopôle Toulouse, France
Int J Geriatr Psychiatry 24:149-55. 2009..The aim of this study is to describe the progression of Alzheimer's disease (AD) in the oldest old (>or=85 years) and to compare it with the younger elderly...
[Behavioral disorders in dementia: intervention study in a long-term care unit]Pierre Jean Ousset
Service de médecine interne et gérontologie clinique, CHU Purpan Casselardit, Toulouse
Psychol Neuropsychiatr Vieil 1:207-12. 2003..They also have a major negative impact on the caregiver's burden. We present an intervention study on the carers of demented patients in a long-term care unit...
Cachexia versus sarcopeniaYves Rolland
INSERM U558, University of Toulouse III, France
Curr Opin Clin Nutr Metab Care 14:15-21. 2011..The review summarizes and discusses the proposed new definitions for sarcopenia and cachexia. It also highlights the overlapping of both conditions and the fact that these conditions frequently occur in elderly patients...
Caloric restriction and brain functionSophie Gillette-Guyonnet
Gérontopôle Toulouse, France
Curr Opin Clin Nutr Metab Care 11:686-92. 2008..caloric restriction on brain functioning? Could caloric restriction be proposed in the future to prevent or treat neurodegenerative disorders such as Alzheimer's disease? Is there a future for caloric restriction interventions in adults?..
Mild cognitive impairment: a nosological entity?Thierry Voisin
Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse University, Toulouse, France
Curr Opin Neurol 16:S43-5. 2003..Future research should be focussed on redefining the criteria of the mild cognitive impairment entity. This could enable the better development of appropriate therapeutic interventions...
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task ForceG Abellan Van Kan
Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
J Nutr Health Aging 13:881-9. 2009....
Descriptive study of nursing home residents from the REHPA networkY Rolland
Gérontopôle de Toulouse, Service de Medecine Interne et de Gerontologie Clinique, Pavillon Junot, 170 avenue de Casselardit, Hopital La Grave Casselardit, 31300 Toulouse, France
J Nutr Health Aging 13:679-83. 2009....
Descriptive analysis of hospitalizations of patients with Alzheimer's disease: a two-year prospective study of 686 patients from the REAL.FR studyT Voisin
Alzheimer s Disease Research Centre CMRR, F CMRR SF, Toulouse University Hospital, France
J Nutr Health Aging 13:890-2. 2009..The aims of the present study were to evaluate the frequency and the causes of hospitalization in a large prospective cohort of mild to moderate patients with AD...
PUFA for prevention and treatment of dementia?I Carrie
Gerontopole, CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
Curr Pharm Des 15:4173-85. 2009..In this review, we summarize preclinical and clinical research suggesting that DHA exerts beneficial effects on cognitive function with ageing...
The primary care physician and Alzheimer's disease: an international position paperH Villars
Gerontopole, Alzheimer s Disease Research and Clinical Center, Toulouse University Hospital, Toulouse, France
J Nutr Health Aging 14:110-20. 2010..It is a matter of patients' right to benefit from access to innovation and clinical research whatever his age or diseases, while of course fully respecting the rules and protective measures that are in force...
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's diseaseSophie Gillette-Guyonnet
Gérontopôle de Toulouse, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France
Alzheimers Dement 5:114-21. 2009..The study also collects imaging and biological data that could be used in future AD prevention and treatment trials...
[Sarcopenia]Y Rolland
Service de médecine interne et gérontologie clinique, Hopital La Grave Casselardit, Gérontopôle de Toulouse, Pavillon Junot, 170, avenue de Casselardit, 31300 Toulouse, France
Rev Med Interne 30:150-60. 2009..The endpoint prevention of mobility disability should be added to the well-established outcomes of treatment of the loss of muscular mass, muscle strength or muscle quality...
Predictive factors of hospitalizations in Alzheimer's disease: a two-year prospective study in 686 patients of the REAL.FR studyT Voisin
Alzheimer s Disease Research Centre CMRR, F CMRR SF, Toulouse University Hospital, France
J Nutr Health Aging 14:288-91. 2010..The objective of the present study was to determine predictive factors for hospitalisation in AD patients...
Follow-up for Alzheimer patients: European Alzheimer Disease Consortium position paperF Nourhashemi
Gerontopole, Hopitaux de Toulouse, France
J Nutr Health Aging 14:121-30. 2010..The aim of this article is to discuss available care strategies once the AD diagnosis has been made and to propose a follow-up plan as standard of care at a European level...
Predictive factors of emergency hospitalisation in Alzheimer's patients: results of one-year follow-up in the REAL.FR CohortL Balardy
Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan Casselardit, F 31300 Toulouse, France
J Nutr Health Aging 9:112-6. 2005..To determine the predictive factors of hospitalisation in patients with Alzheimer's disease followed in the REAL.FR cohort...
Memory complaints to the general practitioner: data from the GuidAge studyN Coley
INSERM, U558, F 31073, Toulouse, France
J Nutr Health Aging 12:66S-72S. 2008..The importance of memory complaints should not be underestimated in clinical practice...
The I.A.N.A Task Force on frailty assessment of older people in clinical practiceG Abellan Van Kan
Department of Geriatric Medicine, Pavillon J P Junod, CHU Toulouse, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
J Nutr Health Aging 12:29-37. 2008....
[Vascular risk factors and Alzheimer's disease]T Voisin
Service de médecine interne et gérontologie clinique, CHU La Grave Casselardit, 170, avenue de Casselardit, 31300 Toulouse, France
Rev Med Interne 24:288s-291s. 2003..The major objective of this study is to analyse the impact of vascular risk factors on natural history of Alzheimer's disease...
